ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Failure of specific active immunotherapy in lung cancer
British Journal of Cancer
◽
10.1038/bjc.1981.217
◽
1981
◽
Vol 44
(4)
◽
pp. 496-501
◽
Cited By ~ 11
Author(s):
R G Souter
◽
P G Gill
◽
A J Gunning
◽
P J Morris
Keyword(s):
Lung Cancer
◽
Active Immunotherapy
◽
Specific Active Immunotherapy
Download Full-text
Related Documents
Cited By
References
Specific Active Immunotherapy in Lung Cancer: The Induction of Long-Lasting Cellular Responses to Tumour-Associated Antigens
Recent Results in Cancer Research - Adjuvant Therapies of Cancer
◽
10.1007/978-3-642-81685-7_37
◽
1982
◽
pp. 232-239
◽
Cited By ~ 4
Author(s):
T. H. M. Stewart
◽
A. C. Hollinshead
◽
J. E. Harris
◽
S. Raman
Keyword(s):
Lung Cancer
◽
Cellular Responses
◽
Active Immunotherapy
◽
Tumour Associated Antigens
◽
Specific Active Immunotherapy
Download Full-text
Faculty Opinions recommendation of Why has active immunotherapy not worked in lung cancer?
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.725690915.793512553
◽
2015
◽
Author(s):
Nico van Zandwijk
Keyword(s):
Lung Cancer
◽
Active Immunotherapy
Download Full-text
Why has active immunotherapy not worked in lung cancer?
Annals of Oncology
◽
10.1093/annonc/mdv323
◽
2015
◽
Vol 26
(11)
◽
pp. 2213-2220
◽
Cited By ~ 23
Author(s):
A. Thomas
◽
G. Giaccone
Keyword(s):
Lung Cancer
◽
Active Immunotherapy
Download Full-text
Establishment of anti-idiotype monoclonal antibodies (Ab2β) for specific and active immunotherapy in lung cancer patients
Lung Cancer
◽
10.1016/0169-5002(95)96323-n
◽
1995
◽
Vol 12
(1-2)
◽
pp. 127
Keyword(s):
Lung Cancer
◽
Monoclonal Antibodies
◽
Cancer Patients
◽
Active Immunotherapy
◽
Lung Cancer Patients
Download Full-text
Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program
BMC Immunology
◽
10.1186/s12865-020-0338-4
◽
2020
◽
Vol 21
(1)
◽
Author(s):
Javier Sánchez Ramírez
◽
◽
Yanelys Morera Díaz
◽
Mónica Bequet-Romero
◽
Francisco Hernández-Bernal
◽
...
Keyword(s):
Cancer Patients
◽
Humoral Response
◽
Active Immunotherapy
◽
Compassionate Use
◽
Specific Active Immunotherapy
◽
Specific Humoral Response
Download Full-text
Antigen-specific active immunotherapy for ovarian cancer
Cochrane Database of Systematic Reviews
◽
10.1002/14651858.cd007287.pub4
◽
2018
◽
Cited By ~ 4
Author(s):
Sterre T Paijens
◽
Ninke Leffers
◽
Toos Daemen
◽
Wijnand Helfrich
◽
H Marike Boezen
◽
...
Keyword(s):
Ovarian Cancer
◽
Active Immunotherapy
◽
Specific Active Immunotherapy
Download Full-text
SPECIFIC ACTIVE IMMUNOTHERAPY USING A RECOMBINANT VACCINIA VIRUS EXPRESSING HUMAN CARCINOEMBRYONIC ANTIGEN (CEA)
Journal of Immunotherapy
◽
10.1097/00002371-199202000-00028
◽
1992
◽
Vol 11
(2)
◽
pp. 129
Author(s):
J. A. Kantor
◽
H. Kauffman
◽
P. F. Robbins
◽
M. Salgaller
◽
K. Irvine
◽
...
Keyword(s):
Vaccinia Virus
◽
Carcinoembryonic Antigen
◽
Recombinant Vaccinia Virus
◽
Active Immunotherapy
◽
Recombinant Vaccinia
◽
Specific Active Immunotherapy
Download Full-text
Cancer Stem Cell Antigens from Autologous Tumor Cell Lines in Patient-Specific Active Immunotherapy for Metastatic Cancer
Stem Cells and Cancer Stem Cells, Volume 9
◽
10.1007/978-94-007-5645-8_26
◽
2012
◽
pp. 271-284
Author(s):
Robert O. Dillman
◽
Andrew N. Cornforth
◽
Carol DePriest
Keyword(s):
Stem Cell
◽
Cancer Stem Cell
◽
Tumor Cell
◽
Cell Lines
◽
Metastatic Cancer
◽
Active Immunotherapy
◽
Patient Specific
◽
Autologous Tumor Cell
◽
Autologous Tumor
◽
Specific Active Immunotherapy
Download Full-text
Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence
British Journal of Cancer
◽
10.1038/bjc.1978.76
◽
1978
◽
Vol 37
(4)
◽
pp. 491-496
◽
Cited By ~ 20
Author(s):
D W Hedley
◽
T J McElwain
◽
G A Currie
Keyword(s):
Malignant Melanoma
◽
Early Recurrence
◽
Active Immunotherapy
◽
Specific Active Immunotherapy
Download Full-text
Invasive melanoma patients treated with Canvaxin specific active immunotherapy show serconversion for both IgG and IgM antibody responses to numerous protein and glycolipid tumor antigens
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.2574
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 2574-2574
Author(s):
S. Kuhns
◽
C. R. Ill
◽
L. Zhang
◽
D. Buckman
◽
J. T. Nguyen
◽
...
Keyword(s):
Tumor Antigens
◽
Antibody Responses
◽
Active Immunotherapy
◽
Igm Antibody
◽
Melanoma Patients
◽
Specific Active Immunotherapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close